prof. Veerle Surmont

Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer : results from the Belgian compassionate use program

Sofie Joris, Thierry Pieters, Anne Sibille, Frederique Bustin, Laurence Jacqmin, Hassan Rezaei Kalantari, Veerle Surmont (UGent) , Jean-Charles Goeminne, Frederic Clinckart, Karin Pat, et al.

(2020) JOURNAL OF GERIATRIC ONCOLOGY. 11(5). p.796-801

Add to list

A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

M. Reck, K. F. Mileham, D. A. Clump, L. Decoster, A. Estival, E. Felip, P. Fried, L. Paz-Ares, M. Sebastian, N Vinolas Segarra, et al.

(2020) ANNALS OF ONCOLOGY. 31(Suppl 4). p.S897-S898

Add to list

Journal Article
A1
open access

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

Lennart Raman (UGent) , Malaïka Van Der Linden (UGent) , Kim Van der Eecken (UGent) , Karim Vermaelen (UGent) , Ingel Demedts, Veerle Surmont (UGent) , Ulrike Himpe, Franceska Dedeurwaerdere, Liesbeth Ferdinande (UGent) , Yolande Lievens (UGent) , et al.

(2020) GENOME MEDICINE. 12(1).

Add to list

The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life : a randomised controlled trial

Gaëlle Vanbutsele (UGent) , Simon Van Belle (UGent) , Veerle Surmont (UGent) , Martine De Laat (UGent) , Roos Colman (UGent) , Kim Eecloo (UGent) , Eline Naert (UGent) , Marc De Man (UGent) , Karen Geboes (UGent) , Luc Deliens (UGent) , et al.

(2020) EUROPEAN JOURNAL OF CANCER. 124. p.186-193

Add to list

Coping strategy influences quality of life in patients with advanced lung cancer

Annelies Janssens, Sofie Derijcke, Danny Galdermans, Veerle Surmont (UGent) , Els De Droogh, Anneke Lefebure, Erika Saenen, Elke Vandenbroucke, Ann-Marie Morel, Anna Sadowska, et al.

(2019) European-Respiratory-Society (ERS) International Congress, Abstracts. In EUROPEAN RESPIRATORY JOURNAL 54(Suppl. 63).

Add to list

Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC

Fabrice Barlesi, Edward B. Garon, Dong-Wan Kim, Enriqueta Felip, Ji-Youn Han, Joo-Hang Kim, Myung-Ju Ahn, Mary Jo Fidler, Matthew A. Gubens, Jr. de Castro, Gilberto, et al.

(2019) JOURNAL OF THORACIC ONCOLOGY. 14(5). p.793-801

Add to list

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial

RS Herbst, P Baas, JL Perez-Gracia, E Felip, D-W Kim, J-Y Han, JR Molina, J-H Kim, C Dubos Arvis, M-J Ahn, et al.

(2019) ANNALS OF ONCOLOGY. 30(2). p.281-289

Add to list

Prognostic understanding and quality of life in patients with advanced lung cancer : a multicenter study

Annelies Janssens, Sofia Derijcke, Danielle Galdermans, Marc Daenen, Veerle Surmont (UGent) , Els De Droogh, Anneke Lefebure, Erika Saenen, Elke Vandenbroucke, Ann-Marie Morel, et al.

(2019) CLINICAL LUNG CANCER. 20(3). p.E369-E375

Add to list

Miscellaneous

Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC (vol 14, pg 793, 2019)

F. Barlesi, E. B. Garon, D-W Kim, F. Enriqueta, J.Y. Han, J.H. Kim, M.J. Ahn, M.J. Fidler, M.A. Gubens, G. de Castro, et al.

(2019) JOURNAL OF THORACIC ONCOLOGY. 14(7). p.1306-1306

Add to list

Journal Article
A1
open access

Staging of nutrition disorders in non-small-cell lung cancer patients : utility of skeletal muscle mass assessment

Sami Antoun, Hugues Morel, Pierre-Jean Souquet, Veerle Surmont (UGent) , David Planchard, Franck Bonnetain, Pascal Foucher, Thomas Egenod, Ivan Krakowski, Helene Gaudin, et al.

(2019) JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE. 10(4). p.782-793

Academic Bibliography

prof. Veerle Surmont

Real life safety and effectiveness of nivolumab in older patients with non-small cell lung cancer : results from the Belgian compassionate use program

A phase I/II trial of radium-223 (Ra-223) in combination with pembrolizumab in patients (pts) with stage IV non-small cell lung cancer (NSCLC)

Shallow whole-genome sequencing of plasma cell-free DNA accurately differentiates small from non-small cell lung carcinoma

The effect of early and systematic integration of palliative care in oncology on quality of life and health care use near the end of life : a randomised controlled trial

Coping strategy influences quality of life in patients with advanced lung cancer

Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC

Use of archival versus newly collected tumor samples for assessing PD-L1 expression and overall survival : an updated analysis of KEYNOTE-010 trial

Prognostic understanding and quality of life in patients with advanced lung cancer : a multicenter study

Health-related quality of life in KEYNOTE-010 : a phase II/III study of pembrolizumab versus docetaxel in patients with previously treated advanced, programmed death ligand 1-expressing NSCLC (vol 14, pg 793, 2019)

Staging of nutrition disorders in non-small-cell lung cancer patients : utility of skeletal muscle mass assessment

Contents

Support

Contact